Epidemiology and control of antibiotic resistance in the intensive care unit
- 1 August 2004
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Infectious Diseases
- Vol. 17 (4) , 309-316
- https://doi.org/10.1097/01.qco.0000136927.29802.68
Abstract
Resistance to antibiotics is very high in the intensive care units of many countries, although there are several exceptions. Some infections are becoming extremely difficult to treat. The risk of cross-transmission of those strains is very high. This review focuses on recent data (2003 to the present) that may help understanding and dealing with this serious public health problem. Intensive care units can be considered as ‘factories’ for creating, disseminating and amplifying resistance to antibiotics, for many reasons: importation of resistant microorganisms at admission, selection of resistant strains with an extensive use of broad-spectrum antibiotics, cross-transmission of resistant strains via the hands or the environment. Some national programs can be considered as failures, as in the UK and the USA. Other countries have been able to maintain a low level of resistance (Scandinavian countries, Netherlands, Switzerland, Germany, Canada). There is clearly an ‘inoculum effect’ above which preventive measures become poorly efficient. Several preventive measures have been proposed including preventive isolation, systematic screening at admission, local, national or international antibiotic guidelines, antibiotic prescriptions advice by infectious-disease teams, antibiotic prevention with selective digestive decontamination, antibiotic strategies such as ‘cycling’, or rather, for some authors, the use of an ‘à la carte’ antibiotic strategy which could be considered as a ‘patient-to-patient antibiotic rotation’. There is obviously an international concern regarding the level of resistance to antibiotics in the intensive-care-unit setting. A strong program including prevention of cross-transmission and better usage of antibiotics seems to be needed in order to be successful. We do not know if this kind of program will enable countries with a very high endemic level of resistance to decrease the level in future years.Keywords
This publication has 100 references indexed in Scilit:
- High antibiotic susceptibility among bacterial pathogens in Swedish ICUs Report from a nation-wide surveillance program using TA90as a novel index of susceptibilityScandinavian Journal of Infectious Diseases, 2004
- Phenotypic resistance testingScandinavian Journal of Infectious Diseases, 2003
- Étude de la corrélation entre les prescriptions d’antibiotiques et les recommandations dans une unité de soins intensifs néonatalsArchives de Pédiatrie, 2003
- Comparative In Vitro Activity of Faropenem and 11 Other Antimicrobial Agents Against 250 Invasive Streptococcus pneumoniae Isolates from FranceEuropean Journal of Clinical Microbiology & Infectious Diseases, 2003
- Resistance in Enterobacteriaceae: Results of a Multicenter Surveillance Study, 1995-2000Infection Control & Hospital Epidemiology, 2003
- Different trends in antibiotic resistance rates at a university teaching hospitalClinical Microbiology & Infection, 2003
- Bacterial Resistance: Origins, Epidemiology, and ImpactClinical Infectious Diseases, 2003
- Comparison of Mortality Associated with Methicillin‐Resistant and Methicillin‐SusceptibleStaphylococcus aureusBacteremia: A Meta‐analysisClinical Infectious Diseases, 2003
- Does Antimicrobial Resistance Cluster in Individual Hospitals?The Journal of Infectious Diseases, 2002
- Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patientsThe Lancet, 2002